<\!DOCTYPE html> IBD with Primary Sclerosing Cholangitis (IBD-PSC) — IBDology · Holubar Lab

← IBDology · Patient Resources · IBD-PSC

IBD with Primary Sclerosing Cholangitis (IBD-PSC)

A patient’s guide to the IBD-PSC overlap: surveillance, cancer risk, transplant, and pouch implications.

Primary sclerosing cholangitis (PSC) and inflammatory bowel disease often travel together — the combination is called IBD-PSC. About 70–80% of patients with PSC also have IBD, most often ulcerative colitis. The combination is different enough from either condition alone that it deserves its own care roadmap.

This page is being authored Detailed patient-friendly content is being prepared by Dr. Holubar and reviewed for accuracy. Section headings below outline the structure; full content will be published soon. For now, the most reliable resources are linked at the bottom of this page.

What is IBD-PSC?

Primary sclerosing cholangitis (PSC) is a chronic disease of the bile ducts — the tubes that carry bile from the liver to the intestine. About 70–80% of patients with PSC also have inflammatory bowel disease, most commonly ulcerative colitis. The combination is called IBD-PSC.

Key fact: IBD-PSC behaves differently from regular IBD. Surveillance, cancer risk, and treatment decisions are different.

Why IBD-PSC is Different

Surveillance Recommendations

Most expert centers recommend annual colonoscopy with chromoendoscopy or high-definition imaging once IBD-PSC is diagnosed. This is more frequent than for IBD alone. Some centers also recommend annual MRCP (an MRI of the bile ducts) to assess PSC progression and screen for bile duct cancer (cholangiocarcinoma).

Pouch Surgery in IBD-PSC

If you have IBD-PSC and need restorative proctocolectomy (J-pouch), choose a high-volume IBD pouch center. Studies show:

Why volume matters: High-volume IBD surgery centers report better outcomes for IBD-PSC patients. The ACS NSQIP IBD Collaborative tracks this systematically.

What to Ask Your Doctor

External Resources